Extreme essential thrombocytosis in a healthy asymptomatic 6-month-old child

In healthy child essential thrombocytosis is always an incidental finding during routine check. Essential thrombocytosis (primary thrombocythemia) is a non-reactive, chronic myeloproliferative disorder in which sustained megakaryocyte proliferation leads to an increase in the number of circulating platelets, on the other hand reactive or secondary thrombocytosis is the more common form, with infectious diseases being the most common cause. Mutations in Janus kinase 2 (JAK2), calreticulin (CALR), or myeloproliferative leukemia (MPL) are found in approximately 90% of patients with essential thrombocytosis. We describe a case of extreme thrombocytosis in a healthy 6-month child. She required admission for workup (maximum number of platelets 1900,000/mm3). With this case, we reviewed the different causes of thrombocytosis in childhood, differential diagnosis, World Health Organization (WHO) criteria for diagnosis of essential thrombocytosis, and the available treatments in case of extreme thrombocytosis.

Authors

Institutions

Publication Details

Journal
International Journal of Contemporary Pediatrics
Published
2024-11-25
DOI
https://doi.org/10.18203/2349-3291.ijcp20243480
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extreme essential thrombocytosis in a healthy asymptomatic 6-month-old child

Mohammed M. Alsultan, Anjana Bhat, F. Harbi
International Journal of Contemporary Pediatrics
Myeloproliferative Neoplasms: Diagnosis and Treatment
article

Extreme essential thrombocytosis in a healthy asymptomatic 6-month-old child

Mohammed M. Alsultan, Anjana Bhat, F. Harbi
article en

Abstract

In healthy child essential thrombocytosis is always an incidental finding during routine check. Essential thrombocytosis (primary thrombocythemia) is a non-reactive, chronic myeloproliferative disorder in which sustained megakaryocyte proliferation leads to an increase in the number of circulating platelets, on the other hand reactive or secondary thrombocytosis is the more common form, with infectious diseases being the most common cause. Mutations in Janus kinase 2 (JAK2), calreticulin (CALR), or myeloproliferative leukemia (MPL) are found in approximately 90% of patients with essential thrombocytosis. We describe a case of extreme thrombocytosis in a healthy 6-month child. She required admission for workup (maximum number of platelets 1900,000/mm3). With this case, we reviewed the different causes of thrombocytosis in childhood, differential diagnosis, World Health Organization (WHO) criteria for diagnosis of essential thrombocytosis, and the available treatments in case of extreme thrombocytosis.

International Journal of Contemporary PediatricsVol. 11(12)
King Fahd Medical City (SA)
Openalex Percentile: Top 62%
Myeloproliferative Neoplasms: Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.